Balance Sheet EDAP TMS S.A.

Equities

EDAP

US2683111072

Advanced Medical Equipment & Technology

Delayed Nasdaq Other stock markets 19:24:59 14/04/2026 +04			5-day change	1st Jan Change
3.305 ^USD	-0.60%		-2.79%	+0.46%

04-06	European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading	MT
04-02	European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading	MT

79f91b0adf0fcc518308cd5c.FyAtXiCBkpLnQAFkmYcdLStCPiHpifdC8bwssuAq8YI.VUJvOUTH3aO2BFEm8PRRV2JyT1izy8UOucQd04IfwN1wEWtpebba2bQzVA

Published financial data: EDAP TMS S.A.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025 (USD)
Revenues	44.06M	55.11M	60.42M	64.12M	70.53M
Other Revenues, Total	5K	-	-	-	-
Total Revenues	44.06M	55.11M	60.42M	64.12M	70.53M
Cost of Goods Sold, Total	25.64M	30.92M	36.01M	37.56M	40.53M
Gross Profit	18.42M	24.19M	24.41M	26.56M	30M
Selling General & Admin Expenses, Total	16.63M	23.53M	33.86M	39.36M	45.04M
R&D Expenses	3.4M	4.92M	6.96M	7.73M	9.66M
Other Operating Expenses, Total	20.03M	28.45M	40.82M	47.09M	54.7M
Operating Income	-1.61M	-4.26M	-16.41M	-20.53M	-24.7M
Interest Expense, Total	-52K	-168K	-232K	-236K	-789K
Interest And Investment Income	10K	404K	1.31M	796K	252K
Net Interest Expenses	-42K	236K	1.08M	560K	-537K
Currency Exchange Gains (Loss)	2.36M	1.92M	-1.8M	1.25M	-1M
Other Non Operating Income (Expenses)	-	-	-2K	-1K	-2.57M
EBT, Excl. Unusual Items	706K	-2.1M	-17.13M	-18.73M	-28.81M
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Other Unusual Items	187K	-	-3.4M	-	-
EBT, Incl. Unusual Items	893K	-2.1M	-20.53M	-18.73M	-28.81M
Income Tax Expense	193K	837K	644K	289K	438K
Earnings From Continuing Operations	700K	-2.93M	-21.18M	-19.02M	-29.25M
Net Income to Company	700K	-2.93M	-21.18M	-19.02M	-29.25M
Net Income - (IS)	700K	-2.93M	-21.18M	-19.02M	-29.25M
Net Income to Common Incl Extra Items	700K	-2.93M	-21.18M	-19.02M	-29.25M
Net Income to Common Excl. Extra Items	700K	-2.93M	-21.18M	-19.02M	-29.25M
Per Share Items
Net EPS - Basic	0.02	-0.09	-0.57	-0.51	-0.78
Basic EPS - Continuing Operations	0.02	-0.09	-0.57	-0.51	-0.78
Basic Weighted Average Shares Outstanding	32.13M	34.39M	37M	37.29M	37.44M
Net EPS - Diluted	0.02	-0.09	-0.57	-0.51	-0.78
Diluted EPS - Continuing Operations	0.02	-0.09	-0.57	-0.51	-0.78
Diluted Weighted Average Shares Outstanding	32.42M	34.39M	37M	37.29M	37.44M
Normalized Basic EPS	0.01	-0.04	-0.29	-0.31	-0.48
Normalized Diluted EPS	0.01	-0.04	-0.29	-0.31	-0.48
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	308K	-2.65M	-14.5M	-17.97M	-21.29M
EBITA	-1.49M	-4.12M	-16.24M	-20.31M	-24.39M
EBIT	-1.61M	-4.26M	-16.41M	-20.53M	-24.7M
EBITDAR	1.26M	-1.59M	-13.13M	-16.67M	-19.8M
Total Revenues (As Reported)	44.06M	55.11M	60.42M	64.11M	70.53M
Effective Tax Rate - (Ratio)	21.61	-39.93	-3.14	-1.54	-1.52
Current Domestic Taxes	320K	485K	77K	46K	45K
Current Foreign Taxes	436K	251K	533K	355K	558K
Total Current Taxes	756K	736K	610K	401K	603K
Deferred Domestic Taxes	-8K	8K	-3K	-5K	-2K
Deferred Foreign Taxes	-556K	93K	37K	-107K	-163K
Total Deferred Taxes	-564K	101K	34K	-112K	-165K
Normalized Net Income	441K	-1.31M	-10.71M	-11.71M	-18M
Non-Cash Pension Expense	6K	11K	34K	35K	-
Supplemental Operating Expense Items
Advertising Expense	490K	929K	1.35M	1.74M	1.95M
Selling and Marketing Expenses	10.73M	16.38M	22.63M	25.28M	27.32M
General and Administrative Expenses	5.9M	7.15M	11.23M	14.08M	17.72M
Research And Development Expense From Footnotes	4.76M	5.75M	7.6M	8.41M	10.1M
Net Rental Expense, Total	953K	1.06M	1.37M	1.3M	1.48M
Imputed Operating Lease Interest Expense	37.54K	147K	284K	219K	444K
Imputed Operating Lease Depreciation	915K	915K	1.08M	1.08M	1.04M
Stock-Based Comp., S&M Exp. (Total)	-	1M	1.8M	-	-
Stock-Based Comp., G&A Exp. (Total)	-	1.1M	4.2M	1.7M	-
Stock-Based Comp., Other (Total)	1.9M	3K	865K	1.58M	2.56M
Total Stock-Based Compensation	1.9M	2.1M	6.86M	3.28M	2.56M

Fiscal Period: December	2021	2022	2023	2024	2025 (USD)
Assets
Cash And Equivalents	47.18M	63.14M	43.47M	29.84M	20.45M
Total Cash And Short Term Investments	47.18M	63.14M	43.47M	29.84M	20.45M
Accounts Receivable, Total	10.25M	12.8M	16.96M	18.3M	21.29M
Other Receivables	1.26M	1.52M	1.38M	1.69M	1.3M
Notes Receivable	615K	617K	896K	306K	-
Total Receivables	12.12M	14.94M	19.24M	20.29M	22.58M
Inventory	7.5M	11.78M	15.11M	18.5M	12.83M
Prepaid Expenses	581K	660K	659K	1.26M	1.3M
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	-	-1K	-	-2K	-
Total Current Assets	67.38M	90.52M	78.48M	69.88M	57.16M
Gross Property Plant And Equipment	15.13M	15.71M	18.58M	21.58M	28.3M
Accumulated Depreciation	-9.96M	-9.73M	-10.39M	-11.25M	-14.79M
Net Property Plant And Equipment	5.17M	5.98M	8.19M	10.34M	13.5M
Goodwill	2.41M	2.41M	2.41M	2.41M	2.83M
Other Intangibles, Total	728K	725K	1.08M	1.08M	1.8M
Accounts Receivable Long-Term	-	-	-	-	546K
Deferred Tax Assets Long-Term	898K	829K	729K	833K	1.09M
Deferred Charges Long-Term	0	0	0	0	0
Other Long-Term Assets, Total	634K	655K	650K	1.52M	2.06M
Total Assets	77.23M	101M	91.55M	86.06M	79M
Liabilities
Accounts Payable, Total	5.51M	6.64M	11.24M	12.56M	11.72M
Accrued Expenses, Total	3.88M	5.26M	6.09M	8.16M	8.4M
Short-term Borrowings	1.92M	1.85M	2.53M	6.3M	6.05M
Current Portion of Long-Term Debt	830K	1.6M	1.55M	2.41M	2.12M
Current Portion of Leases	1.01M	1.12M	1.09M	1.17M	1.24M
Current Income Taxes Payable	501K	219K	77K	-8K	193K
Unearned Revenue Current, Total	3.87M	4.05M	4.05M	6.64M	7.1M
Other Current Liabilities	431K	960K	967K	587K	311K
Total Current Liabilities	17.95M	21.71M	27.6M	37.81M	37.14M
Long-Term Debt	4.93M	3.59M	2M	2.16M	15.9M
Long-Term Leases	1.32M	1.22M	1.32M	1.94M	2.43M
Unearned Revenue Non Current	440K	727K	1.11M	794K	1.41M
Pension & Other Post Retirement Benefits	2.28M	1.96M	2.24M	2.18M	2.1M
Other Non Current Liabilities	252K	284K	371K	283K	594K
Total Liabilities	27.17M	29.49M	34.63M	45.17M	59.58M
Common Stock, Total	4.39M	4.78M	4.85M	4.89M	6.07M
Additional Paid In Capital	89.62M	114M	121M	124M	151M
Retained Earnings	-39.44M	-42.37M	-63.55M	-82.57M	-129M
Treasury Stock	-928K	-897K	-800K	-800K	-1.02M
Comprehensive Income and Other	-3.59M	-3.83M	-4.49M	-4.89M	-8.34M
Total Common Equity	50.05M	71.63M	56.92M	40.9M	19.41M
Total Equity	50.05M	71.63M	56.92M	40.9M	19.41M
Total Liabilities And Equity	77.23M	101M	91.55M	86.06M	79M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	33.47M	36.93M	37.1M	37.39M	37.48M
ECS Total Common Shares Outstanding	33.47M	36.91M	37.1M	37.39M	37.48M
Book Value / Share	1.5	1.94	1.53	1.09	0.52
Tangible Book Value	46.91M	68.5M	53.43M	37.4M	14.78M
Tangible Book Value Per Share	1.4	1.86	1.44	1	0.39
Total Debt	10.01M	9.39M	8.48M	13.97M	27.75M
Net Debt	-37.18M	-53.75M	-34.99M	-15.86M	7.29M
Debt Equivalent of Unfunded Proj. Benefit Obligation	2.38M	2.15M	2.31M	2.32M	-
Debt Equivalent Oper. Leases	7.62M	8.5M	10.94M	10.42M	11.88M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	4.96M	7.54M	8.97M	13.81M	9.24M
Inventories - Work In Process, Total	250K	283K	512K	1.02M	1.52M
Inventories - Finished Goods, Total	3.76M	5.22M	6.89M	5.72M	3.56M
Machinery, Total	11.44M	11.91M	14.69M	16.32M	20.23M
Full Time Employees	227	264	307	310	-
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Assets on Operating Lease - Gross	423K	753K	885K	1.48M	3.62M
Assets on Operating Lease - Accumulated Depreciation	-108K	-264K	-207K	-337K	-510K
Accumulated Allowance for Doubtful Accounts (Supple)	742K	161K	224K	372K	-

Fiscal Period: December	2021	2022	2023	2024	2025 (USD)
Net Income	700K	-2.93M	-21.18M	-19.02M	-29.25M
Depreciation & Amortization - CF	1.8M	1.46M	1.74M	2.34M	3.1M
Amortization of Goodwill and Intangible Assets - (CF)	125K	141K	175K	220K	304K
Depreciation & Amortization, Total	1.92M	1.6M	1.91M	2.56M	3.41M
(Gain) Loss From Sale Of Asset	142K	266K	1K	515K	529K
Stock-Based Compensation (CF)	1.9M	2.1M	6.86M	3.28M	2.56M
Provision and Write-off of Bad Debts	363K	124K	422K	955K	919K
Other Operating Activities, Total	-1.1M	127K	202K	78K	2.49M
Change In Accounts Receivable	-103K	-1.97M	-4.91M	-139K	-567K
Change In Inventories	166K	-4.48M	-4.21M	-4.04M	6.85M
Change In Accounts Payable	-38K	1.14M	5.28M	1.24M	-2.96M
Change in Other Net Operating Assets	496K	997K	938K	983K	-390K
Cash from Operations	4.44M	-3.02M	-14.68M	-13.58M	-16.41M
Capital Expenditure	-1.55M	-2.18M	-3.76M	-3.87M	-4.93M
Sale (Purchase) of Intangible assets	-92K	-137K	-534K	-230K	-832K
Investment in Marketable and Equity Securities, Total	13K	-	1K	-	-
Other Investing Activities, Total	-5K	-58K	-49K	-19K	44K
Cash from Investing	-1.64M	-2.38M	-4.34M	-4.12M	-5.72M
Short Term Debt Issued, Total	-	-	656K	3.72M	-
Long-Term Debt Issued, Total	1.06M	286K	-	2.58M	12.42M
Total Debt Issued	1.06M	286K	656K	6.3M	12.42M
Short Term Debt Repaid, Total	-717K	-38K	-	-	-883K
Long-Term Debt Repaid, Total	-1.81M	-1.15M	-1.83M	-1.78M	-2.92M
Total Debt Repaid	-2.52M	-1.19M	-1.83M	-1.78M	-3.81M
Issuance of Common Stock	21.73M	24.6M	261K	116K	-
Other Financing Activities, Total	1K	-1.96M	-	-1K	-
Cash from Financing	20.27M	21.74M	-911K	4.64M	8.61M
Foreign Exchange Rate Adjustments	-585K	-388K	268K	-566K	2.97M
Miscellaneous Cash Flow Adjustments	-	1K	-	-	-1K
Net Change in Cash	22.49M	15.95M	-19.66M	-13.64M	-10.54M
Supplemental Items
Cash Interest Paid	114K	168K	265K	281K	562K
Cash Income Tax Paid (Refund)	307K	410K	509K	377K	366K
Levered Free Cash Flow	2.64M	-5.62M	-8.25M	-10.75M	-12.13M
Unlevered Free Cash Flow	2.67M	-5.52M	-8.11M	-10.6M	-11.64M
Change In Net Working Capital	-1.5M	4.25M	2.33M	-484K	-3.59M
Net Debt Issued / Repaid	-1.47M	-905K	-1.17M	4.52M	8.61M

Fiscal Period: December	2021	2022	2023	2024	2025 (USD)
Profitability
Return on Assets	-1.52	-2.98	-10.65	-14.45	-18.33
Return on Total Capital	-2.07	-3.77	-14.01	-21.34	-29.64
Return On Equity %	1.83	-4.82	-32.95	-38.88	-94.5
Return on Common Equity	1.83	-4.82	-32.95	-38.88	-94.5
Margin Analysis
Gross Profit Margin %	41.81	43.9	40.4	41.42	42.54
SG&A Margin	37.74	42.7	56.04	61.4	63.85
EBITDA Margin %	0.7	-4.81	-24	-28.03	-30.18
EBITA Margin %	-3.37	-7.47	-26.87	-31.68	-34.58
EBIT Margin %	-3.66	-7.72	-27.16	-32.03	-35.01
Income From Continuing Operations Margin %	1.59	-5.32	-35.05	-29.66	-41.47
Net Income Margin %	1.59	-5.32	-35.05	-29.66	-41.47
Net Avail. For Common Margin %	1.59	-5.32	-35.05	-29.66	-41.47
Normalized Net Income Margin	1	-2.38	-17.72	-18.26	-25.53
Levered Free Cash Flow Margin	5.98	-10.21	-13.66	-16.77	-17.2
Unlevered Free Cash Flow Margin	6.06	-10.02	-13.42	-16.54	-16.5
Asset Turnover
Asset Turnover	0.67	0.62	0.63	0.72	0.84
Fixed Assets Turnover	8.18	9.88	8.52	6.92	5.82
Receivables Turnover (Average Receivables)	4.22	4.78	4.06	3.64	3.5
Inventory Turnover (Average Inventory)	3.31	3.21	2.68	2.24	2.53
Short Term Liquidity
Current Ratio	3.75	4.17	2.84	1.85	1.54
Quick Ratio	3.27	3.57	2.24	1.32	1.16
Operating Cash Flow to Current Liabilities	0.25	-0.14	-0.53	-0.36	-0.44
Days Sales Outstanding (Average Receivables)	86.52	76.34	89.9	100.63	104.26
Days Outstanding Inventory (Average Inventory)	110.23	113.81	136.28	163.74	144.3
Average Days Payable Outstanding	81.4	63.01	82.92	106.35	132.38
Cash Conversion Cycle (Average Days)	115.35	127.15	143.27	158.03	116.18
Long Term Solvency
Total Debt/Equity	19.99	13.11	14.91	34.17	142.92
Total Debt / Total Capital	16.66	11.59	12.97	25.47	58.84
LT Debt/Equity	12.48	6.71	5.82	10.03	94.44
Long-Term Debt / Total Capital	10.4	5.94	5.06	7.47	38.87
Total Liabilities / Total Assets	35.18	29.16	37.82	52.48	75.43
EBIT / Interest Expense	-31	-25.34	-70.74	-87.01	-31.3
EBITDA / Interest Expense	24.25	-9.46	-56.6	-70.62	-25.1
(EBITDA - Capex) / Interest Expense	-5.63	-22.46	-72.82	-87.02	-31.34
Total Debt / EBITDA	7.93	-5.91	-0.65	-0.84	-1.4
Net Debt / EBITDA	-29.48	33.8	2.66	0.95	-0.37
Total Debt / (EBITDA - Capex)	-34.15	-2.49	-0.5	-0.68	-1.12
Net Debt / (EBITDA - Capex)	126.88	14.25	2.07	0.77	-0.29
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	5.77	25.06	9.64	6.11	1.63
Gross Profit, 1 Yr. Growth %	0.24	31.33	0.9	8.79	4.37
EBITDA, 1 Yr. Growth %	-89.28	-961.04	446.72	23.93	9.46
EBITA, 1 Yr. Growth %	-268.79	176.8	294.48	25.11	10.93
EBIT, 1 Yr. Growth %	-309.9	164.08	285.53	25.12	11.11
Earnings From Cont. Operations, 1 Yr. Growth %	-141.08	-519	622.06	-10.2	42.08
Net Income, 1 Yr. Growth %	-141.08	-519	622.06	-10.2	42.08
Normalized Net Income, 1 Yr. Growth %	-202.62	-396.88	717.46	9.31	42.11
Diluted EPS Before Extra, 1 Yr. Growth %	-133.33	-550.02	536.03	-10.9	41.49
Accounts Receivable, 1 Yr. Growth %	-3.67	24.93	32.47	7.86	12
Inventory, 1 Yr. Growth %	-6.13	57.09	28.29	22.39	-33.22
Net Property, Plant and Equip., 1 Yr. Growth %	-7.63	15.7	36.92	26.16	25.77
Total Assets, 1 Yr. Growth %	39.92	30.94	-9.47	-5.99	-11.64
Tangible Book Value, 1 Yr. Growth %	103.31	46	-22	-30	-61.95
Common Equity, 1 Yr. Growth %	90.7	43.11	-20.54	-28.15	-54.31
Cash From Operations, 1 Yr. Growth %	124.84	-168.03	385.38	-7.45	11.6
Capital Expenditures, 1 Yr. Growth %	-16.9	40.48	72.33	2.9	17.62
Levered Free Cash Flow, 1 Yr. Growth %	17.17	-313.3	46.74	30.25	3.68
Unlevered Free Cash Flow, 1 Yr. Growth %	15.16	-306.77	46.9	30.76	0.84
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-0.95	15.01	17.1	7.86	-0.29
Gross Profit, 2 Yr. CAGR %	-6.35	14.74	15.11	4.77	2.31
EBITDA, 2 Yr. CAGR %	-72.52	5.72	585	160.3	11.83
EBITA, 2 Yr. CAGR %	-19.84	228.68	230.55	122.16	13.11
EBIT, 2 Yr. CAGR %	-14.42	298.55	219.18	119.63	13.21
Earnings From Cont. Operations, 2 Yr. CAGR %	-31.96	31.2	450.04	154.64	8.45
Net Income, 2 Yr. CAGR %	-31.96	31.2	450.04	154.64	8.45
Normalized Net Income, 2 Yr. CAGR %	-43.24	32.83	392.64	198.92	19.67
Diluted EPS Before Extra, 2 Yr. CAGR %	-36.76	22.48	435	138.06	7.8
Accounts Receivable, 2 Yr. CAGR %	-4.88	9.7	28.65	19.53	3.38
Inventory, 2 Yr. CAGR %	-4.24	21.43	41.96	25.3	-14.97
Net Property, Plant and Equip., 2 Yr. CAGR %	-12.24	3.38	25.86	31.43	18.49
Total Assets, 2 Yr. CAGR %	20.63	35.36	8.88	-7.75	-14.27
Tangible Book Value, 2 Yr. CAGR %	39.3	72.29	6.71	-26.11	-51.45
Common Equity, 2 Yr. CAGR %	35.26	65.2	6.64	-24.44	-46.1
Cash From Operations, 2 Yr. CAGR %	8.15	23.68	81.72	111.94	-2.42
Capital Expenditures, 2 Yr. CAGR %	4.76	8.05	55.59	33.16	5.61
Levered Free Cash Flow, 2 Yr. CAGR %	29.91	70.36	76.89	38.25	11.88
Unlevered Free Cash Flow, 2 Yr. CAGR %	26.6	65.9	74.26	38.6	10.56
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	3.99	7.06	13.19	13.31	2.91
Gross Profit, 3 Yr. CAGR %	2.88	4.83	9.92	12.96	1.84
EBITDA, 3 Yr. CAGR %	1.45	-13.38	82.82	287.43	89.79
EBITA, 3 Yr. CAGR %	7.26	21.16	249.3	139.11	71.53
EBIT, 3 Yr. CAGR %	7.02	24.59	294.16	133.59	70.32
Earnings From Cont. Operations, 3 Yr. CAGR %	27.47	24.72	131.64	200.62	104.02
Net Income, 3 Yr. CAGR %	27.47	24.72	131.64	200.62	104.02
Normalized Net Income, 3 Yr. CAGR %	228.04	-1.47	143.42	198.24	127.06
Diluted EPS Before Extra, 3 Yr. CAGR %	19.72	21.64	112.09	194.35	94.8
Accounts Receivable, 3 Yr. CAGR %	-4.81	4.17	16.82	21.31	12.29
Inventory, 3 Yr. CAGR %	1.31	12.94	23.67	35.11	-2.47
Net Property, Plant and Equip., 3 Yr. CAGR %	7.12	-3.77	13.53	25.96	24.34
Total Assets, 3 Yr. CAGR %	16.58	23.98	18.37	3.68	-12.7
Tangible Book Value, 3 Yr. CAGR %	29.29	41.5	32.29	-7.28	-43.14
Common Equity, 3 Yr. CAGR %	26.1	37.83	29.44	-6.51	-38.66
Cash From Operations, 3 Yr. CAGR %	193.95	-7.33	95.08	45.12	66.57
Capital Expenditures, 3 Yr. CAGR %	2.79	15.52	26.24	35.56	24.34
Levered Free Cash Flow, 3 Yr. CAGR %	-1.1	53.26	62.09	59.74	22.47
Unlevered Free Cash Flow, 3 Yr. CAGR %	0.16	49.09	59.31	58.35	21.55
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	4.37	9.04	9.05	7.38	7.59
Gross Profit, 5 Yr. CAGR %	2.38	10.32	7.61	4.8	6.81
EBITDA, 5 Yr. CAGR %	-25.96	42.33	117.92	34.52	50.18
EBITA, 5 Yr. CAGR %	29.97	16.08	68.23	54.41	122.49
EBIT, 5 Yr. CAGR %	35.04	16	65.67	56.3	139.31
Earnings From Cont. Operations, 5 Yr. CAGR %	-28.86	33.92	128.77	65.93	70.99
Net Income, 5 Yr. CAGR %	-28.86	33.92	128.77	65.93	70.99
Normalized Net Income, 5 Yr. CAGR %	-30.68	48.22	285.98	53.59	83.23
Diluted EPS Before Extra, 5 Yr. CAGR %	-31.23	30.79	117.89	59.12	61.8
Accounts Receivable, 5 Yr. CAGR %	2.31	2.57	7.37	10.06	11.25
Inventory, 5 Yr. CAGR %	-1.36	11.82	15.95	17.73	6.46
Net Property, Plant and Equip., 5 Yr. CAGR %	13.3	10.2	14.25	9.01	15.49
Total Assets, 5 Yr. CAGR %	10.63	16.61	13.44	10.15	4.04
Tangible Book Value, 5 Yr. CAGR %	16.47	25.25	19.74	9.12	-11.41
Common Equity, 5 Yr. CAGR %	15.41	23.28	17.92	8.37	-8.83
Cash From Operations, 5 Yr. CAGR %	29.74	-0.23	142.51	29.02	47.87
Capital Expenditures, 5 Yr. CAGR %	5.77	6.16	21.33	22.28	17.55
Levered Free Cash Flow, 5 Yr. CAGR %	18.45	16.38	24.8	47.07	39.75
Unlevered Free Cash Flow, 5 Yr. CAGR %	18.01	16.19	25	44.8	37.65